Alimera Sciences Inc Asset Turnover Ratio (ALIM), as of second quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Alimera Sciences Inc  (NASDAQ: ALIM)
 

Alimera Sciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Alimera Sciences Inc asset turnover ratio, the ability of Alimera Sciences Inc's assets to generate revenue in the second quarter 2024, increased sequentially to 0.64 in the second quarter (Jun 30 2024), yet the ratio remained below the average, as ALIM's position remain challenging.

Within sector 171 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2024 compared to the preceding quarter from 3227 to 3259.

Asset Turnover Ratio Definition



ALIM Asset Turnover Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Asset Change -3.33 % 215.75 % 259.71 % 255.04 % 225.61 %
Y / Y Revenue Change 52.92 % 67.27 % 89.98 % 66.25 % 17.18 %
Asset Turnover Ratio (TTM) 0.64 0.58 0.63 0.67 0.81
ALIM's Total Ranking # 3259 # 3227 # 1652 # 1652 # 1652
Seq. Asset Change -1.99 % -0.6 % -0.61 % -0.15 % 220.12 %
Seq. Revenue Change 15.5 % -14.99 % 17.9 % 32.1 % 26.33 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 172
Healthcare Sector # 507
Overall Market # 3259

Asset Turnover Ratio Statistics
High Average Low
7.94 3.61 2.59
(Dec 31 2014)   (Sep 30 2016)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Medinotec Inc   1.80 $ 6.931  Millions$ 3.845  Millions
Rockwell Medical inc   1.78 $ 92.909  Millions$ 52.133  Millions
The Oncology Institute Inc   1.78 $ 361.067  Millions$ 202.932  Millions
Evofem Biosciences Inc   1.74 $ 17.714  Millions$ 10.161  Millions
Rosecliff Acquisition Corp I  1.72 $ 22.531  Millions$ 13.101  Millions
Neuraxis Inc   1.70 $ 2.267  Millions$ 1.331  Millions
Psychemedics Corporation  1.69 $ 20.169  Millions$ 11.924  Millions
Sunlink Health Systems Inc   1.68 $ 32.442  Millions$ 19.316  Millions
Privia Health Group Inc   1.65 $ 1,695.679  Millions$ 1,025.359  Millions
Cv Sciences Inc   1.65 $ 14.932  Millions$ 9.049  Millions
Docgo Inc   1.64 $ 774.613  Millions$ 472.272  Millions
Agile Therapeutics Inc  1.62 $ 19.722  Millions$ 12.179  Millions
Electromedical Technologies Inc   1.62 $ 1.203  Millions$ 0.743  Millions
P3 Health Partners Inc   1.60 $ 1,402.857  Millions$ 876.636  Millions
Encision Inc   1.58 $ 6.563  Millions$ 4.151  Millions
Kewaunee Scientific Corporation  1.57 $ 201.625  Millions$ 128.699  Millions
Mimedx Group Inc   1.54 $ 337.828  Millions$ 219.983  Millions
Procyon Corporation  1.53 $ 4.984  Millions$ 3.264  Millions
Progyny Inc   1.52 $ 1,131.451  Millions$ 744.017  Millions
International Stem Cell Corporation  1.51 $ 8.322  Millions$ 5.499  Millions
Stablecoin Development Corporation  1.49 $ 11.596  Millions$ 7.792  Millions
Iridex Corp  1.49 $ 50.099  Millions$ 33.682  Millions
Zynex inc   1.44 $ 193.614  Millions$ 134.118  Millions
Innovage Holding Corp   1.42 $ 763.855  Millions$ 538.718  Millions
Aspira Women s Health inc   1.41 $ 9.172  Millions$ 6.512  Millions
Option Care Health Inc   1.41 $ 4,589.168  Millions$ 3,264.701  Millions
Chemed Corporation  1.40 $ 2,335.557  Millions$ 1,673.198  Millions
Vycor Medical Inc   1.35 $ 1.359  Millions$ 1.003  Millions
Viemed Healthcare Inc   1.32 $ 205.699  Millions$ 155.779  Millions
Myomo Inc   1.31 $ 21.079  Millions$ 16.087  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.